Bivalent chromatin as a therapeutic target in cancer: An in silico predictive approach for combining epigenetic drugs

Tomás Alarcón, Josep Sardanyés, Antoni Guillamón, Javier A. Menéndez. Bivalent chromatin as a therapeutic target in cancer: An in silico predictive approach for combining epigenetic drugs. PLoS Computational Biology, 17(6), 2021. [doi]

Abstract

Abstract is missing.